Pediatric infectious diseases: 2009 update for the Rogers' Textbook of Pediatric Intensive Care

Alice D Ackerman1, Sunit Singhi

  • 1Department of Pediatrics (ADA), Virginia Tech Carilion School of Medicine, Roanoke, VA, USA. aackerman@carilion.com

Insights

This review covers recent advances in pediatric infectious diseases for critical care units, highlighting treatment updates and the growing challenge of antimicrobial resistance in children globally.

Area of Science:

  • Infectious Diseases in Pediatric Critical Care

Background:

  • Review of key infectious disease literature published after the 4th edition of Rogers' Textbook of Pediatric Intensive Care.
  • Focus on conditions relevant to pediatric critical care units.
  • Incorporates recent advancements in understanding and treating pediatric infections.

Purpose of the Study:

  • To synthesize current knowledge on pediatric infectious diseases for critical care.
  • To identify significant updates in diagnosis and management.
  • To address emerging challenges like antimicrobial resistance.

Main Methods:

  • Comprehensive literature search of the U.S. National Library of Medicine.
  • Keywords included critical care, nosocomial infections, antimicrobial resistance, sepsis, CNS infections, and specific diseases (e.g., measles, HIV, botulism, aspergillosis).
  • Inclusion of articles based on clinical relevance by study authors.

Main Results:

  • Advances in understanding and treating various pediatric infectious diseases.
  • Disparities in outcomes between developed and developing countries noted.
  • Emerging threat of antimicrobial resistance and limited new anti-infective agents.
  • Updated guidelines for septic shock, HIV-related opportunistic infections.
  • Specific findings on measles, bacterial meningitis, botulism, and pediatric aspergillosis.

Conclusions:

  • Continuous progress in pediatric infectious disease management.
  • Antimicrobial resistance poses a significant future challenge for pediatric intensive care units worldwide.
  • Evidence-based guidelines and reevaluation of treatment strategies are crucial.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...